Share Name Share Symbol Market Type Share ISIN Share Description
Brainjuicer LSE:BJU London Ordinary Share GB00B1GVQH21 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +3.50p +0.59% 593.50p 580.00p 607.00p 593.50p 588.50p 590.00p 4,540.00 13:26:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Media 25.2 4.5 24.0 24.7 73.37

Brainjuicer (BJU) Latest News

More Brainjuicer News
Brainjuicer Takeover Rumours

Brainjuicer (BJU) Share Charts

1 Year Brainjuicer Chart

1 Year Brainjuicer Chart

1 Month Brainjuicer Chart

1 Month Brainjuicer Chart

Intraday Brainjuicer Chart

Intraday Brainjuicer Chart

Brainjuicer (BJU) Discussions and Chat

Brainjuicer Forums and Chat

Date Time Title Posts
18/1/201718:25Brainjuicer - Fresher Insights, Better Marketing210.00

Add a New Thread

Brainjuicer (BJU) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Brainjuicer trades in real-time

Brainjuicer (BJU) Top Chat Posts

Brainjuicer Daily Update: Brainjuicer is listed in the Media sector of the London Stock Exchange with ticker BJU. The last closing price for Brainjuicer was 590p.
Brainjuicer has a 4 week average price of 556.09p and a 12 week average price of 516.18p.
The 1 year high share price is 593.50p while the 1 year low share price is currently 270p.
There are currently 12,362,544 shares in issue and the average daily traded volume is 2,191 shares. The market capitalisation of Brainjuicer is £73,371,698.64.
longshanks: I believe the share price may have reached an all-time high
longshanks: £5.50 would mark an all time high for the share price.This new creative agency is an interesting development and could radically change the way that advertising is commissioned. I spoke to a senior advertising executive about it; told him that the proposition was to guarantee an ROI to customers of advertising content. He said that is crazy.It could be a crazy notion but to my mind it may mean the advertising world has become complacent to customers' needs. This could pay off handsomely for Brainjuicer and us shareholders. £5.50 represents full value on current performance but could look very cheap in a few years time.
sinkersimon: From the AGM statement:- "Investment in support of anticipated continued long-term growth, and in particular the expansion of our client account management teams, is expected to give rise to a somewhat higher rate of cost growth from the second quarter of the year onwards. The sharp rise in the BrainJuicer share price during 2013 and early 2014 will likely lead to a much higher share based payment charge in 2014 than would otherwise have been the case. We anticipate a total charge of around GBP1m for share based payments and related National Insurance payments. The comparable charge for 2013 was GBP0.3m." A 20% drop in share price immediately followed the above.
kenmitch: Didn't get a reply about Director selling following a post saying "why would anyone sell?" Now we know the answer. Not holding fortunately having sold for a good profit a while ago, and won't be buying now. Thanks longshanks for your posts. You helped convince me to buy and the too high PE was the reason for selling in time. Hope the share price recovers for those still holding.
kenmitch: Also agree re Stephan Shakespeare. Unfortunately analysts - and probably bb posters - seem to judge the sector on YOU, probably because it is their UK surveys and polls that receive media coverage. When TOLUNA was quoted few even seemed to know the Company existed, or that their share price went UP during the 2008 bear market,and was finally taken private at 3 times their start price.Also they came to the market on a PE around 70 from memory! Nor did they realise that TOL was larger than YOU. Eurovestech still hold a fair sized stake in TOL. It was a multi multi bagger for Eurovestech from their original £2 million stake. Their shares too are unloved and worth checking out as they are trading at a very large NAV discount despite buybacks. So it's worth anyone making judgements about Brainjuicer based on the very poor recent YOU record, doing some more research. THEN come back if finding negatives.
longshanks: I think that is a fair assessment kenmitch. I also tend to feel that the "sell in May, return on St Leger day" adage had more validity when the summer hiatus was taken without the benefit of iPhones/iPads/WiFi etc. These days - it is easy for traders (and PI's) to be aware of market bargains and take advantage of them from the beach. I somehow feel that with a market cap above £30m - BJU is now firmly in the radar of many small cap funds. The company has not put a foot wrong in five years and has crossed that difficult transition between being an owner-led start-up with a bright idea and a business with a diverse client base and world-class management. BrainJuicer could become a very "hot" stock and the share price could surge to a seriously high PER and a PEG factor well in excess of 1. PER and PEG can be useful indicators when judging the risk of buying a company's stock - but because they are historic measures and don't account for how growth could be delivered in the future can also be wholly misleading. Many of these new investors are paying prices in excess of Hoodless Brennan's 12 month target price announced earlier this year. They have done due diligence, done some serious research and IMHO have come to similar conclusions to my own. I anticipate some volatility around £2.75p but for the price to then cruise more or less effortlessly to £4 or £5 this year. I could trade the peaks and dips - but I seriously doubt I would be much better off. Someone sold a few shares yesterday and turned a few hundred quids return on one months investment - however I will be surprised if they can buy back in below the price they sold at. I have bought more or less every month over the last two years and will carry on doing so whilst I think they offer good value. I believe this share will give me a return in excess of 2000% over the next ten years: that makes £2.50 per share a steal.
longshanks: So now we know the source of the share trades this morning: RNS Number : 9562F BrainJuicer Group PLC 04 May 2011 Press Release 4 May 2011 BrainJuicer Group PLC ("BrainJuicer" and the "Company") Director Dealing Given the level of institutional demand in the Company's shares, John Kearon and James Geddes, respectively the Company's Chief Executive Officer and the Chief Financial Officer, have sold respectively 700,000 ordinary shares and 75,000 ordinary shares in the Company all at a price of 250 pence per ordinary share. -------------------- I am always a little sceptical of Directors who justify their sales as being to "satisfy institutional demand". Ultimately they are selling shares because they can and they like the price they are being offered. It is always nice to have lots of institutions craving your stock but they can be very fickle bed fellows and not always the type of investor you want to attract. However I think I was right this morning when I suggested that demand is being led by a desire by brokers to make a market in these shares. We should see better liquidity as a result and if the company continues to deliver good growth there is nothing to say that the share price won't continue to climb. I haven't too many examples of companies that have been in similar situations but one cautionary tale that comes to mind is that of Pressure Technologies. In January 2008, Directors sold a tranche of shares to "satisfy institutional demand" and, indeed, demand did seem to be sustained for a while with the share price cruising from £2 to £3 over eight months through to September 2008. However the price subsequently cooled off when results didn't quite live up to expectations; we also had the banking crisis, government defence cuts and BP's deep-sea drilling disaster in close succession and these wouldn't have helped. The price has since that time ebbed and flowed and lived for much of that time at a price below £2.
longshanks: BOOM....there goes the last of the Unilever Ventures holdings at £2.35. Seem to have a bunch of institutions taking on the bulk of it - we should get some RNS' in the next day of two. ---------------- I also suspect that BJ may have bought some of these shares into treasury to continue/complete funding the Employee Benefit Trust. This EBT is a model of operation that many other public companies should perhaps consider running. Basically there is a long term incentive scheme that has been set up by the company whereby key personnel can be awarded shares if the share price meets certain performance criteria at the end of April 2014. A share price below £3 and the employees get nothing, Above £5 and they get a decent wad of shares and considerably more if the share price is £7 or above. Up to 1.12m shares could be handed out in 3 years time but the company is funding this incentive scheme ahead of 2014 by sensibly buying shares in the market whilst the price is still low. To date they have 660000 in treasury for these purposes. It has not been confirmed but I would not be surprised if they took up some of the UV shares divested today - perhaps spending up to £1m to finance it which, given the healthy balance sheet and fantastic cash flows, would be easily financed.
kenmitch: Ditto. Thanks longshanks. Spotted your reminder on the Net Dimensions bb and have been checking them out, finishing with some excellent posts here. Should have bought them ages ago and not at 249p! The obvious place for the proceeds from the Toluna bid due next month. Yes, the PE ratio is quite high. But Toluna's was over 50 for a good while and more than that when they floated and it didn't stop the share price quadrupling. I don't know enough about Brainjuicer to have any idea whether their share price can do as well in time. Wish I had followed up your suggestion to look at these in 2009 instead of today.
stegrego: Never seen this before.... Dear LCF Research subscriber, We would like to draw your attention to the fact that Sharemark, the online stock market for smaller companies, is hosting a special Christmas Auction in shares of BrainJuicer Group Plc at 17:00 on Wednesday, the 22nd of December (tomorrow). BrainJuicer is the AIM listed online market research agency that we frequently cover on LCF Research. BrainJuicer is somewhat unusual in that it is a profitable, cash generative and dividend paying company that also has good organic growth prospects in a large global industry. Its share price has traded down slightly in recent days on a volume of less than 6,000 shares, though as of 15:00 today there were not any shares on offer. BrainJuicer shares are traded on both AIM and Sharemark, and executing trades through Sharemark is an excellent way for buyers and sellers to set share prices independently of the market maker because it is an order driven trading platform. The Sharemark system works in tandem with AIM - limit orders entered on Sharemark will be executed on AIM if the marketmaker is willing to trade at the price entered. However, if the trade cannot be done on AIM, the system automatically matches orders of buyers and sellers on Sharemark directly - enabling a true market price to be set even at low trading volumes. The cut-off time for submitting a bid to buy or sell BJU shares is 16:30 tomorrow, though bid and offers can be placed at any time between now and then. We expect that there will be bids and offers for BJU posted on Sharemark tomorrow. To place a bid/offer, contact your broker and request a Sharemark transaction at your limit price (many stockbrokers are already approved on the Sharemark system - if yours is not, you may be able to open an account at The Share Centre online).
Brainjuicer share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170119 15:10:23